Niels Claessens

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet · 2019 · 2.1K citations

Platinum–etoposide Versus Platinum–etoposide, Medicine, Pharmacology +6

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet Oncology · 2020 · 662 citations · Full text

Platinum–etoposide Versus Platinum–etoposide, Medicine, Pathology +6

Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study

Karlijn de Joode, Daphne W. Dumoulin, Jolien Tol et al. · European Journal of Cancer · 2020 · 77 citations · Full text

Epidemiology, Cancer Epidemiology, Medicine +10

Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non–Small-Cell Lung Cancer

Lissete Sánchez‐Magraner, Juan Gumuzio, James Miles et al. · Journal of Clinical Oncology · 2023 · 74 citations · Full text

Screening childhood contacts of patients with smear-positive pulmonary tuberculosis in Malawi.

Niels Claessens, F Gausi, S Meijnen et al. · PubMed · 2002 · 48 citations

Childhood Contacts, Tuberculosis Prevention, Pediatric Lung Disease +20